Results 71 to 80 of about 1,043 (146)

Issue Information

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 8, Page 1285-1288, August 2025.
wiley   +1 more source

Maribavir [PDF]

, 2020
openaire   +1 more source

Tackling CMV in Transplant Recipients: Past, Present, and Future

Infectious Diseases and Therapy
Cytomegalovirus (CMV), a beta-herpesvirus capable of maintaining lifelong latency, presents a substantial risk to transplant recipients, resulting in significant morbidity and mortality among both hematopoietic stem cell and solid organ transplantation ...
Tal Schlaeffer-Yosef, Lior Nesher
doaj   +1 more source

Individualizing Treatment for CMV with UL97 del597-599 Mutation: Beyond Unusual Response to a Lower Ganciclovir Dose Increase

Brazilian Journal of Transplantation
Human cytomegalovirus (CMV) infection is the most prevalent infection affecting organ transplant recipients, and it is a cause of morbidity and mortality in patients undergoing kidney transplantation.
Ana Piedade, Helena Vidal, Pilar Simões, Miguel Bigotte Vieira , Maria Jesus Chasqueira , Fernando Caeiro, Inês Aires , Paulo Paixão, Cristina Jorge   +8 more
doaj  

Maribavir for cytomegalovirus retinitis: A case series and review of the literature. [PDF]

AJO Int
Shughoury A, Emami S, Kaisari E, Kharouba R, Thomas AS, Goldstein DA, Janetos TM.   +6 more
europepmc   +1 more source

Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries. [PDF]

BMC Infect Dis
Prats JAGG, Farsi KA, Al-Khabori M, Al-Saadawi N, Alshemmari SH, Cherif H, Ibrahim D, Kaloyannidis P, Swaka RLSW.   +8 more
europepmc   +1 more source

Optimizing maribavir management: The role of health system specialty pharmacies in access, monitoring, and waste reduction. [PDF]

J Manag Care Spec Pharm
Donald DR, Zuckerman AD, Dee K, Gargurevich N, Choi L, Oboh S, Renfro CP.   +6 more
europepmc   +1 more source

Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient. [PDF]

Pediatr Blood Cancer
Joshua B, Goodell EB, Curtis DJ, McLaughlin L, Strommen A, Lind KT.   +5 more
europepmc   +1 more source

A Novel Case of CMV Resistance to Valganciclovir and Maribavir in a Renal Transplant Patient

Transplant International
Helen Pearce, Emma K. Montgomery, Neil Sheerin, Neil Sheerin, Helena Ellam   +4 more
doaj   +1 more source

New evidence in the management of CMV infection: impact on prophylaxis and treatment. [PDF]

Rev Esp Quimioter
Fortún J.
europepmc   +1 more source